![Sriram Ryali](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sriram Ryali
Directeur Financier/CFO chez
CARIBOU BIOSCIENCES, INC.
Fortune : 40 970 $ au 31/05/2026
Profil
Sriram Ryali is Chief Financial & Accounting Officer at Caribou Biosciences, Inc. since 2025.
Former roles include Chief Financial & Accounting Officer at Codexis, Inc. from 2023 to 2024, Chief Financial Officer at Eiger BioPharmaceuticals, Inc. from 2018 to 2023, Vice President-Finance at Aimmune Therapeutics, Inc. from 2017 to 2018, Head-Medical Affairs, Technical Operations, R&D at Onyx Pharmaceuticals, Inc. from 2013 to 2015, and Senior Director-Financial Planning & Analysis at Jazz Pharmaceuticals Plc.
Education includes undergraduate studies at the University of California, Los Angeles and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 17 360 ( 0,02% ) | 40 970 $ | 31/05/2026 |
Postes actifs de Sriram Ryali
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur Financier/CFO | 02/01/2025 |
Anciens postes connus de Sriram Ryali
| Sociétés | Poste | Fin |
|---|---|---|
| CODEXIS, INC. | Directeur Financier/CFO | 30/09/2024 |
| EIGER BIOPHARMACEUTICALS | Directeur Financier/CFO | 20/01/2023 |
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2018 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Directeur Technique/Scientifique/R&D | 01/01/2015 |
| JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Formation de Sriram Ryali
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
